Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
German Merck Plans US$107.67 million Plant in China
Merck KGaA plans to construct a new plant in China to manufacture diabetes drugs and address critical healthcare needs of the Chinese population Location The new plant is planned to be built in Shaghai, China covering an area of 40,000 square meters The plant will have a room for a 20,000squaremeter expansion
KBR Arm to Build Oral Solid Dosage Plant for Prudue Pharma
Prudue Pharma Manufacturing LP has entered into an agreement with KBR Ltds KBR Services Group subsidiary for the construction of a 150,000squarefoot steelframed Oral Solid Dosage manufacturing plant in Treyburn Corporate Park, Durham The new facilitys construction began this year and is expected to be completed by 2015 Budget
UPM Pharmaceuticals Expands Bristol Plant
UPM Pharmaceuticals has announced that as a part of a multitier plan to update the facility, it is currently planning to expand its Bristol plant Background This 475,000square foot commercial manufacturing facility was acquired from Pfizer to provide largescale commercial capabilities for manufacturing and packaging of solid
GVK Biosciences Plans New API Facility in Visakhapatnam
Introduction GVK Biosciences plans to set up a second Active Pharmaceutical Ingredients APIs manufacturing facility in Visakhapatnam It has an existing plant in Hyderabad with a capacity of 135 kilolitres Features The new facility would have a production capacity o
WuXi PharmaTech’s New R&D and cGMP Manufacturing Campus in Changzhou
Introduction SynTheAll STA Pharmaceuticals Co, Ltd, a manufacturing subsidiary of WuXi PharmaTech has begun construction of a new and fully integrated RD and cGMP manufacturing site in Changzhou, 110 miles west of Shanghai, China This construction is aimed at fulfilling the rapidly increasing demands of WuXis manufacturing services
AbbVie’s First Manufacturing Facility in Singapore (US$ 320 million)
Introduction AbbVie is all set to install its first manufacturing facility in Asia which will be operational from 2019 Located in Singapore, this facility will support an emerging antibodydrug conjugate ADC pipeline This would be the first facility of AbbVie since it had split out of Abbott Laboratories in 2012 and made its own identity
Eli Lilly to upgrade Brazil production site with 15 million real ($6.4 million)
Introduction US pharma major Eli Lillys subsidiary in Brazil invests 15 million real US$64 million over the next two years to renew the packaging plant located in Sao Paulo, Brazil Expansion Strategy The site currently makes 10 million packages a year The investment is set to boost product
GSK to invest £200m in UK
Introduction With an effort of strengthening its services, Glaxo Smith Kline has announced a series of investments in the UK that approximately sum up to 200 million These investments will support the companys production of antibiotic medicine and create a centre for pharmaceutical manufacturing innovation in the UK
Multiple Expansion Plans For Bangladesh's Pharmaceutical Industry
The three leading pharmaceutical companies of Bangladesh, Acme Laboratories, Square Pharmaceuticals and Advanced Chemical Industries have taken up major expansion plans at Dhamrai, Kaliakoi and Narayanganj Another pharmaceutical company, Eskayef Bangladesh Ltd completed work on its new plant in August 2008 Acme Laboratories new construction started...
Piramal to establish first private opium processing company
The Mumbaibased Piramal Healthcare plans to set up a manufacturing unit to process raw opium for pharmaceutical use It helps domestic pharma companies in locally procuring opiumbased products like morphine, codeine and thebaine Indian opium contains a range of chemical compounds such as morphine, codeine, thebaine, noscapine and papaverine, which h...
